Mrdenovic, S., Zhang, Y., Wang, R., Yin, L., Chia Yi Chu, G., Yin, L. ... Chung, L. W. K. (2019). Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer, 125. (13), 2222-2232. doi: 10.1002/cncr.32033
Mrdenovic, Stefan, et al. "Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer, vol. 125, no. 13, 2019, pp. 2222-2232. https://doi.org/10.1002/cncr.32033
Mrdenovic, Stefan, Yi Zhang, Ruoxiang Wang, Lijuan Yin, Gina Chia Yi Chu, Liyuan Yin, Michael Lewis, Marija Heffer, Haiyen E. Zhau and Leland W. K. Chung. "Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer 125, no. 13 (2019): 2222-2232. https://doi.org/10.1002/cncr.32033
Mrdenovic, S., et al. (2019) 'Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate', Cancer, 125(13), pp. 2222-2232. doi: 10.1002/cncr.32033
Mrdenovic S, Zhang Y, Wang R, Yin L, Chia Yi Chu G, Yin L, and sur.. Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer [Internet]. 2019 [cited 2024 October 27];125(13):2222-2232. doi: 10.1002/cncr.32033
S. Mrdenovic, et al., "Targeting Burkitt Lymphoma with a Tumor Cell-specific Heptamethine Carbocyanine-cisplatin Conjugate", Cancer, vol. 125, no. 13, pp. 2222-2232, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:153476. [Accessed: 27 October 2024]